0 results available. Select is focused ,type to refine list, press Down to open the menu,
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Income Tax Expense CAGR (7y) in the growth category include:
Seven-year compound annual growth rate in provision for taxes.
Income Tax Expense CAGR (7y) measures the seven-year compound annual growth rate in Income Tax Expense.
Compound annual growth rate (CAGR) is a commonly used business and investing term that measures the growth of a metric over multiple periods. CAGRs are useful since they reduce the effect of volatility in specific periods, unlike arithmetic means.
You can find the calculation details for GSK’s Income Tax Expense CAGR outlined below. The calculation starts by listing values for Income Tax Expense for the last eight fiscal years that are required to calculate CAGR:
| Fiscal Year | Income Tax Expense | YoY Growth |
|---|---|---|
| 2017-12-31T00:00:00.000Z | 1.356 B | |
| 2018-12-31T00:00:00.000Z | 754 M | −44.4% |
| 2019-12-31T00:00:00.000Z | 953 M | 26.4% |
| 2020-12-31T00:00:00.000Z | 67 M | −93.0% |
| 2021-12-31T00:00:00.000Z | 83 M | 23.9% |
| 2022-12-31T00:00:00.000Z | 707 M | 751.8% |
| 2023-12-31T00:00:00.000Z | 756 M | 6.9% |
| 2024-12-31T00:00:00.000Z | 526 M | −30.4% |
Using the values for Income Tax Expense listed in the table above, we can calculate three-year Income Tax Expense CAGR as follows:
Number of years = 7
Multiplier = £526 M / £1.356 B = 0.39
7 Year CAGR = 0.39 ^ (1/7) - 1 = −12.7%
Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. GSK’s reports in the GBP currency. You can read more about Income Tax Expense here and compound annual growth rate on Wikipedia. You may also find variants three-year Income Tax Expense CAGR, and five-year Income Tax Expense CAGR useful.
The chart above depicts the distribution of income tax expense cagr (7y) for companies operating in the Healthcare sector in the Developed economic region. Over 575 companies were considered in this analysis, and 556 had meaningful values. The average income tax expense cagr (7y) of companies in the sector is 8.9% with a standard deviation of 27.2%.
GSK plc DRC's Income Tax Expense CAGR (7y) of -12.7% ranks in the 15.8% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 580 |
| Included Constituents | 556 |
| Min | -39.4% |
| Max | 121.4% |
| Median | 5.1% |
| Mean | 8.9% |
| Standard Deviation | 27.2% |
You can find companies with similar income tax expense cagr (7y) using this stock screener.